Refractory Ocular Behçet’s Disease; Outcome of Low Dose Infliximab

Rheumatology Research
doi 10.22631/rr.2019.69997.1070
Full Text
Abstract

Available in full text

Date
Authors
Publisher

eJournalPlus

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy